Roche Holding AG RHHBY

Company Overview

Roche Holding AG is a Switzerland‑based global healthcare company operating primarily in the pharmaceuticals and diagnostics industries. The company focuses on discovering, developing, and commercializing innovative medicines and diagnostic solutions aimed at improving patient outcomes. Roche’s business is driven by prescription pharmaceuticals, in‑vitro diagnostics, and integrated healthcare solutions that combine diagnostics with targeted therapies. Its primary customer segments include hospitals, laboratories, physicians, healthcare providers, and public health systems.

Founded in 1896 in Basel, Switzerland, Roche began as a manufacturer of branded medicines and vitamins before evolving into one of the world’s largest biotechnology‑focused healthcare companies. A defining strategic shift occurred in the late 20th century with increased investment in biotechnology and personalized medicine, reinforced by the acquisition of Genentech and the expansion of its diagnostics franchise. Roche is widely recognized for its leadership in oncology, immunology, and molecular diagnostics, supported by a strong research‑driven culture and long product life cycles.